You D. Deng
Anshan Road 154
Xiaobailou, 300052, China
Xiaobailou, 300052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Depression and suicide-related events associated with tenofovir use in chronic hepatitis B: A pharmacovigilance analysis.
Journal: Clinical and molecular hepatology
Published: February 12, 2026
Multisystem toxicity and non-cirrhotic portal hypertension linked to arsenic exposure from a traditional herbal preparation.
Journal: Gastroenterology report
Published: January 14, 2026
Association of alkaline phosphatase, γ-glutamyl transferase, total bilirubin, and bile acid levels with HCC risk: a systematic review and meta-analysis.
Journal: European journal of medical research
Published: October 16, 2025
Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China.
Journal: Journal of clinical and translational hepatology
Published: January 21, 2025
New predictors of recurrence in post-polypectomy surveillance - A retrospective analysis of risk stratification for advanced adenomas and polyps.
Journal: Revista espanola de enfermedades digestivas
Published: November 19, 2024
Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database.
Journal: Frontiers in pharmacology
Published: July 20, 2024
Serum uric acid and mortality in metabolic dysfunction-associated steatotic liver disease: Subgroup differences.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: May 31, 2024
Impacts of cardiometabolic risk factors and alcohol consumption on all-cause mortality among MASLD and its subgroups.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: January 19, 2024
Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis.
Journal: JHEP reports : innovation in hepatology
Published: January 11, 2024
MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population.
MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population.
Journal: Annals of hepatology
Published: October 07, 2023
Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients.
Journal: Hepatology communications
Published: February 06, 2023
The Use of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide for Preventing Vertical Transmission of Hepatitis B.
Journal: Journal of clinical gastroenterology
Published: January 04, 2023
Last Updated: 09/26/2026